NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is ...
NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today ...
One in eight U.S. women will be diagnosed with breast cancer during their lifetime, and many of these patients will undergo a lumpectomy, a surgical treatment to remove the tumor while preserving as ...
The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...
Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...
NEWTON, Mass., Dec. 18, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with ...
DEAR MAYO CLINIC: I understand surgery is often included as part of the treatment plan for breast cancer. If I'm a candidate for lumpectomy but am also considering a mastectomy, what are some things I ...
(HealthDay News) — In a study of 241 ,597 women who had breast conservation surgery for breast cancer, 23.6% needed a second operation. The report was published online November 12 in JAMA Surgery. Lee ...
A groundbreaking study published in JAMA Oncology in 2024 has upended traditional thinking surrounding breast cancer surgery. This expansive study, which tracked over 661,000 women over the course of ...
Ultrasound follow-up documented predictable scaffold bioresorption and progressive soft-tissue regrowth REGENERA™ did not interfere with imaging, preserving full assessability of surrounding breast ...
Independent investigators from the University of Pisa presented new data at the 2026 European Congress of Radiology (ECR) Ultrasound follow-up documented predictable scaffold bioresorption and ...